• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 20, 2009

4 Key GI Trends in 2009

Author(s):

Rich Site Summary, VinceZ

This is an exciting time to be in the endoscopy center business. Although there are many pressures on the industry, there are also some terrific opportunities to be gained by the consistent focus in a few key areas.

This is an exciting time to be in the endoscopy center business. Although there are many pressures on the industry, there are also some terrific opportunities to be gained by the consistent focus in a few key areas. Below are four key trends we at Physicians Endoscopy see for 2009, along with some helpful hints to improve your practice and center.

1. Offset CMS declines by bold third-party payor renegotiations.

In the last six months of 2008, I met with probably about 20 potential GI centers in which our company was considering purchasing a minority equity position. Being relatively new to the acquisition business, we didn't quite know what to expect — however, we often found what we clearly did not expect: Many of these centers hadn't actively negotiated their third-party payor contracts in years. Even in those ASCs that did, many of the practices affiliated with the respective facilities often didn't re-negotiate their professional fees at all.

Renegotiating your fees isn't about being greedy — it's simply about receiving the compensation you deserve for the quality, safety-focused patient care you provide. Medicare will continue to decline in reimbursement over the next several years — and on top of that there's probably a good chance that further cuts are ahead to help pay for the multi-trillion dollar governmental bailouts occurring these days. Third-party payors clearly have a different view of the contracting world. Most, but not all, are willing to increase their fees when pressed — particularly if the facility can demonstrate it runs a quality-focused service program. Be assertive, even aggressive in your re-contracting efforts. Show the quality data you've harnessed to prove you are good. Expect increases — don't take no for an answer.

2. Ancillary revenue streams can be captured.

Gastroenterology services are an inbound pathway into the healthcare system. An amazing array of ancillary revenue streams stem from a simple colonoscopy. In a recent analysis of a coalition of 10 GI physicians in a major northeast urban area, we determined that more than $3M dollars of radiology business is generated from the physician coalition annually. Another $1.5M in pathology revenue is generated. Various other revenues from oncology, anesthesiology, surgery as well as inpatient admissions are recognized as well.

For today's GI physician, there is a focus on legally capturing some of these revenue streams. Two common methods focus on the pathology and anesthesiology portions of the outpatient visit. There are a number of models in the market that allow the GI physician to enjoy a financial benefit, in a legally compliant fashion, in the anesthesia revenue stream. Hiring the MD anesthesiologists and CRNAs and billing for their services is one approach. Other non-employee models exist as well — consult your healthcare attorney for their advice and direction as to the best model for you.

The pathology revenue stream can also be attractive to today's GI physician. Many models exist in the United States, all of which tie back to the "in-office ancillary exception" regulations. All these models have one common thread — they operate exclusively through the professional practice, not the ASC. Pathology is a Stark-regulated designated health service, so keep it out of your ASC financials.

A word of strong caution for those ASCs in which a hospital joint venture exists: Tread lightly. The ancillary revenue streams may look attractive at first; however, these services may be very important to your hospital partner — and partners need to work together, not against each other.

3. There's a new emphasis on quality.

Quality has always been the cornerstone of almost every GI center but sometimes the message emphasizing this quality got lost in the mix in past years. It is so rewarding to see the momentum of a renewed focus on quality and quality measurement gaining such a strong foothold in our marketplace. Many people deserve a tremendous amount of thanks and appreciation — folks like Irving Pike, MD, down in Norfolk, Vir., who took it upon himself to be one of the many town criers of this important message.

As another example, scope reprocessing has got to be one of the most tedious jobs in the endoscopy center. That said, it is probably also the most important responsibility for any of your staff members. Every scope must go through a distinct, multi-step process to ensure it is clean and safe for patient care. If your ASC board hasn't reviewed your reprocessing protocols recently, it's time you hold your next meeting in the decontamination room and get acquainted with the most important room in the house.

We firmly believe that quality will someday allow those that can live it, demonstrate it, measure it and report it to receive increased financial benefits. Pay for performance isn't ready for primetime yet in most markets, but preparing your practice and center for the future can improve your local reputation today while positioning you for better reimbursement in the future.

4. Basics deliver.

A focus on implementing strong business fundamentals is now, more than ever, vital to your continued success in today's GI center. Let's face it: There's plenty of pressure on reimbursement, increasing staffing costs, higher supply costs and a parade of other horribles that could begin to degrade your profitability. Maybe that is already happening.

Now is the time to institute strong business rules in your center. A focus on driving utilization while aggressively renegotiating payor contracts will deliver positive results on the revenue portion of your financial statements. On the expense side, evaluate all vendor agreements annually and selectively re-bid contracts even if you are happy with a vendor's current services — the end result generally is you retain the same vendor but at a lower cost per unit. Ensure your staff is "right sized" and the amount of staff each day is tailored to your caseload. Staffing expenses are typically the largest expense item in the facility — generally 25-30 percent of your budget. Reward employees that come forth with cost saving ideas — no matter how small the savings; reward the behavior and this culture.

1. Offset CMS declines by bold third-party payor renegotiations.

In the last six months of 2008, I met with probably about 20 potential GI centers in which our company was considering purchasing a minority equity position. Being relatively new to the acquisition business, we didn't quite know what to expect — however, we often found what we clearly did not expect: Many of these centers hadn't actively negotiated their third-party payor contracts in years. Even in those ASCs that did, many of the practices affiliated with the respective facilities often didn't re-negotiate their professional fees at all.

Renegotiating your fees isn't about being greedy — it's simply about receiving the compensation you deserve for the quality, safety-focused patient care you provide. Medicare will continue to decline in reimbursement over the next several years — and on top of that there's probably a good chance that further cuts are ahead to help pay for the multi-trillion dollar governmental bailouts occurring these days. Third-party payors clearly have a different view of the contracting world. Most, but not all, are willing to increase their fees when pressed — particularly if the facility can demonstrate it runs a quality-focused service program. Be assertive, even aggressive in your re-contracting efforts. Show the quality data you've harnessed to prove you are good. Expect increases — don't take no for an answer.

2. Ancillary revenue streams can be captured.

Gastroenterology services are an inbound pathway into the healthcare system. An amazing array of ancillary revenue streams stem from a simple colonoscopy. In a recent analysis of a coalition of 10 GI physicians in a major northeast urban area, we determined that more than $3M dollars of radiology business is generated from the physician coalition annually. Another $1.5M in pathology revenue is generated. Various other revenues from oncology, anesthesiology, surgery as well as inpatient admissions are recognized as well.

For today's GI physician, there is a focus on legally capturing some of these revenue streams. Two common methods focus on the pathology and anesthesiology portions of the outpatient visit. There are a number of models in the market that allow the GI physician to enjoy a financial benefit, in a legally compliant fashion, in the anesthesia revenue stream. Hiring the MD anesthesiologists and CRNAs and billing for their services is one approach. Other non-employee models exist as well — consult your healthcare attorney for their advice and direction as to the best model for you.

The pathology revenue stream can also be attractive to today's GI physician. Many models exist in the United States, all of which tie back to the "in-office ancillary exception" regulations. All these models have one common thread — they operate exclusively through the professional practice, not the ASC. Pathology is a Stark-regulated designated health service, so keep it out of your ASC financials.

A word of strong caution for those ASCs in which a hospital joint venture exists: Tread lightly. The ancillary revenue streams may look attractive at first; however, these services may be very important to your hospital partner — and partners need to work together, not against each other.

3. There's a new emphasis on quality.

Quality has always been the cornerstone of almost every GI center but sometimes the message emphasizing this quality got lost in the mix in past years. It is so rewarding to see the momentum of a renewed focus on quality and quality measurement gaining such a strong foothold in our marketplace. Many people deserve a tremendous amount of thanks and appreciation — folks like Irving Pike, MD, down in Norfolk, Vir., who took it upon himself to be one of the many town criers of this important message.

As another example, scope reprocessing has got to be one of the most tedious jobs in the endoscopy center. That said, it is probably also the most important responsibility for any of your staff members. Every scope must go through a distinct, multi-step process to ensure it is clean and safe for patient care. If your ASC board hasn't reviewed your reprocessing protocols recently, it's time you hold your next meeting in the decontamination room and get acquainted with the most important room in the house.

We firmly believe that quality will someday allow those that can live it, demonstrate it, measure it and report it to receive increased financial benefits. Pay for performance isn't ready for primetime yet in most markets, but preparing your practice and center for the future can improve your local reputation today while positioning you for better reimbursement in the future.

4. Basics deliver.

A focus on implementing strong business fundamentals is now, more than ever, vital to your continued success in today's GI center. Let's face it: There's plenty of pressure on reimbursement, increasing staffing costs, higher supply costs and a parade of other horribles that could begin to degrade your profitability. Maybe that is already happening.

Now is the time to institute strong business rules in your center. A focus on driving utilization while aggressively renegotiating payor contracts will deliver positive results on the revenue portion of your financial statements. On the expense side, evaluate all vendor agreements annually and selectively re-bid contracts even if you are happy with a vendor's current services — the end result generally is you retain the same vendor but at a lower cost per unit. Ensure your staff is "right sized" and the amount of staff each day is tailored to your caseload. Staffing expenses are typically the largest expense item in the facility — generally 25-30 percent of your budget. Reward employees that come forth with cost saving ideas — no matter how small the savings; reward the behavior and this culture.

Critical footnote

Patient safety is top priority at your ASC and this must never be forgotten or sacrificed. In reviewing any financial, operational or other possible change at your ASC, always implement the "sniff test" to ensure the modification will have no negative impact on patient safety (and satisfaction). One bad patient outcome is a horrible thing and could also rip apart years' worth of your hard work, taking down your ASC business in the process. Be safe.

Mr. Poisson ( jpoisson@endocenters.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it ) is executive vice president and strategic partnerships officer for Physicians Endoscopy, which develops and manages endoscopic ASCs in partnership with practicing GI physicians and hospitals. Learn more about Physicians Endoscopy.

Poisson, J. 4 Key GI Trends in 2009. Retrieved February 20, 2009, from

http://www.beckersasc.com/news-analysis-asc/business-financial-benchmar

king/4-key-gi-trends-in-2009.html

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Advertisement
Health care professional with cannabis, CBD oil -- Image credit: Elroi | stock.adobe.com
June 25th 2025

Real-World Data Suggests Cannabis Use is Associated With Major Adverse Cardiovascular Events

Gillian McGovern, Associate Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Water coming from a faucet - Image credit: Ajax9 | stock.adobe.com
June 25th 2025

Is Fluoride Friend or Foe?

Jim Ruble, PharmD, JD
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty
June 24th 2025

Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty

Danielle Valletti, Assistant Editor
various pills - Image credit: Jiri Hera | stock.adobe.com
June 24th 2025

Journavx From Vertex Pharmaceuticals Inc

Monica Holmberg, PharmD, BCPS
Related Content
Advertisement
Health care professional with cannabis, CBD oil -- Image credit: Elroi | stock.adobe.com
June 25th 2025

Real-World Data Suggests Cannabis Use is Associated With Major Adverse Cardiovascular Events

Gillian McGovern, Associate Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Water coming from a faucet - Image credit: Ajax9 | stock.adobe.com
June 25th 2025

Is Fluoride Friend or Foe?

Jim Ruble, PharmD, JD
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty
June 24th 2025

Timing of Antihypertensive Medication Yields No Benefit in Older Adults With Frailty

Danielle Valletti, Assistant Editor
various pills - Image credit: Jiri Hera | stock.adobe.com
June 24th 2025

Journavx From Vertex Pharmaceuticals Inc

Monica Holmberg, PharmD, BCPS
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.